Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune-checkpoint inhibitor resistance in cancer treatment: Current progress and future directions
Chenyue Zhang, Chenxing Zhang, Haiyong Wang
Cancer Letters (2023) Vol. 562, pp. 216182-216182
Closed Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Plant-nanoparticles enhance anti-PD-L1 efficacy by shaping human commensal microbiota metabolites
Yun Teng, Chao Luo, Xiaolan Qiu, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 4
Multimodal analysis of cfDNA methylomes for early detecting esophageal squamous cell carcinoma and precancerous lesions
Jiaqi Liu, Lijun Dai, Qiang Wang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Lovastatin/SN38 co-loaded liposomes amplified ICB therapeutic effect via remodeling the immunologically-cold colon tumor and synergized stimulation of cGAS-STING pathway
Yi Yang, Jialong Qi, Jialin Hu, et al.
Cancer Letters (2024) Vol. 588, pp. 216765-216765
Closed Access | Times Cited: 10
CLINICAL DEVELOPMENT OF IMMUNO-ONCOLOGY THERAPEUTICS
Jianxin Wang, Qi Chen, Qi Shan, et al.
Cancer Letters (2025), pp. 217616-217616
Closed Access | Times Cited: 1
A PD‐L1 Antibody‐Conjugated PAMAM Dendrimer Nanosystem for Simultaneously Inhibiting Glycolysis and Promoting Immune Response in Fighting Breast Cancer
Peng Zhang, Zhi Li, Weiling Cao, et al.
Advanced Materials (2023) Vol. 35, Iss. 41
Open Access | Times Cited: 18
Anti‐angiogenic therapy enhances cancer immunotherapy: Mechanism and clinical application
Anqi Li, Jian‐Hong Fang
Deleted Journal (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 7
Single-cell characterization of infiltrating T cells identifies novel targets for gallbladder cancer immunotherapy
Yi‐Jian Zhang, Chunman Zuo, Yang Li, et al.
Cancer Letters (2024) Vol. 586, pp. 216675-216675
Open Access | Times Cited: 7
Understanding the dynamics of TKI-induced changes in the tumor immune microenvironment for improved therapeutic effect
Conghua Lu, Ziyuan Gao, Di Wu, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 6, pp. e009165-e009165
Open Access | Times Cited: 7
Tumor-associated macrophages in non-small-cell lung cancer: From treatment resistance mechanisms to therapeutic targets
Zhenjun Huang, Ziqi Xiao, Li‐Qing Yu, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 196, pp. 104284-104284
Open Access | Times Cited: 6
Diffuse intrinsic pontine glioma (DIPG): A review of current and emerging treatment strategies
Luke J. Weisbrod, Thiraviyam Anand, Raghupathy Vengoji, et al.
Cancer Letters (2024) Vol. 590, pp. 216876-216876
Closed Access | Times Cited: 6
Recent advances in Artemisia argyi Levl. et Vant. polysaccharides: Extractions, purifications, structural characteristics, pharmacological activities, and existing and potential applications
Wenjing Hu, Aiqi Yu, Haizheng Bi, et al.
International Journal of Biological Macromolecules (2024) Vol. 279, pp. 135250-135250
Closed Access | Times Cited: 4
NI-3201 Is a Bispecific Antibody Mediating PD-L1–Dependent CD28 Co-stimulation on T Cells for Enhanced Tumor Control
Sara Majocchi, Pauline Lloveras, Lise Nouveau, et al.
Cancer Immunology Research (2025), pp. OF1-OF19
Closed Access
Interrogation of the Tumor Microenvironment by Nanoparticles
Prasanta Panja, Upender Manne, Vibhudutta Awasthy, et al.
Cancer Letters (2025), pp. 217454-217454
Closed Access
Galectin‐1‐Induced Tumor Associated Macrophages Repress Antitumor Immunity in Hepatocellular Carcinoma Through Recruitment of Tregs
Xizhi Yu, Junjie Qian, Limin Ding, et al.
Advanced Science (2025)
Open Access
Combination of cadonilimab (PD-1/CTLA-4 bispecific antibody) and apatinib as salvage therapy achieves partial response in MSI-H advanced gastric cancer: a case report
Jiayu Zhao, Xiaoxiao Li, Xiaoyuan Sun, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
The C/EBPβ antagonist peptide lucicebtide (ST101) induces macrophage polarization toward a pro-inflammatory phenotype and enhances anti-tumor immune responses
Claudio Scuoppo, Rick Ramirez, Siok Leong, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Osteopontin promotes tumor microenvironment remodeling and therapy resistance
Chao Liu, Shunjin Xia, Wei Wang, et al.
Cancer Letters (2025), pp. 217618-217618
Closed Access
Combination therapy with immune checkpoint inhibitors in colorectal cancer: Challenges, resistance mechanisms, and the role of microbiota
Ali Rahimi, Zeinab Baghernejadan, Ali Hazrati, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 186, pp. 118014-118014
Closed Access
Identification of ferroptosis-related gene signatures as a novel prognostic model for clear cell renal cell carcinoma
Xiaoxiao Du, Haoyuan Cao, Yujie Zhou, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Clinical characteristics and novel strategies of immune checkpoint inhibitor rechallenge therapy for non-small cell lung cancer: a comprehensive review
Hao Zhang, Yujun Hu, Tingting Wu, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 4
LncRNAs and the Cancer Epigenome: Mechanisms and Therapeutic Potential
Revathy Nadhan, Ciro Isidoro, Yong Sang Song, et al.
Cancer Letters (2024) Vol. 605, pp. 217297-217297
Closed Access | Times Cited: 4
Changing landscape of anti-angiogenic therapy: Novel approaches and clinical perspectives
Rajesh N. Gacche
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 189020-189020
Closed Access | Times Cited: 10
Prognostic significance of Lymphocyte-activation gene 3 (LAG3) in patients with solid tumors: a systematic review, meta-analysis and pan-cancer analysis
Rongyang Li, Jianhao Qiu, Zhan Zhang, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 10
Targeting acid ceramidase enhances antitumor immune response in colorectal cancer
Yadu Vijayan, Shirley James, Viswanathan Arun, et al.
Journal of Advanced Research (2023) Vol. 65, pp. 73-87
Open Access | Times Cited: 9
Biological mechanisms of resistance to immune checkpoint inhibitors and overcoming this resistance: Challenges in medical oncology
Yuliia Moskalenko
Regulatory Mechanisms in Biosystems (2024) Vol. 15, Iss. 1, pp. 83-91
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top